Drug General Information
Drug ID
D0P0MP
Former ID
DIB019398
Drug Name
compound 28
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529358], [541679]
Structure
Download
2D MOL
Formula
C22H33N2O6P
InChI
InChI=1S/C22H33N2O6P/c1-15(2)12-19(23-16(3)25)21(26)24-11-7-10-20(24)31(29,30)14-18(22(27)28)13-17-8-5-4-6-9-17/h4-6,8-9,15,18-20H,7,10-14H2,1-3H3,(H,23,25)(H,27,28)(H,29,30)/t18-,19+,20+/m1/s1
InChIKey
DGMLSHVZZKUDPN-AABGKKOBSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Recombinant human angiotensin converting enzyme 2 Target Info Inhibitor [529358]
KEGG Pathway Renin-angiotensin system
Protein digestion and absorption
Reactome Metabolism of Angiotensinogen to Angiotensins
WikiPathways ACE Inhibitor Pathway
Metabolism of Angiotensinogen to Angiotensins
References
Ref 529358Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2. J Med Chem. 2008 Apr 10;51(7):2216-26.
Ref 541679(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6555).
Ref 529358Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2. J Med Chem. 2008 Apr 10;51(7):2216-26.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.